136 related articles for article (PubMed ID: 23255951)
1. Differential expression of the Na(+)/I(-) symporter protein in thyroid cancer and adjacent normal and nodular goiter tissues.
Wang S; Liang J; Lin Y; Yao R
Oncol Lett; 2013 Jan; 5(1):368-372. PubMed ID: 23255951
[TBL] [Abstract][Full Text] [Related]
2. Low Iodine in the Follicular Lumen Caused by Cytoplasm Mis-localization of Sodium Iodide Symporter may Induce Nodular Goiter.
Huang H; Shi Y; Liang B; Cai H; Cai Q
Biol Trace Elem Res; 2017 Oct; 179(2):165-171. PubMed ID: 28190186
[TBL] [Abstract][Full Text] [Related]
3. Disparity expression of gammaH2AX in papillary thyroid cancer and nodular goiter.
Hu S; Zhang G; Xu J; Zhu X; Lu X; Jiang L; Wang Q; Hou X; Cao J; Ge M
Clin Lab; 2014; 60(12):2031-7. PubMed ID: 25651738
[TBL] [Abstract][Full Text] [Related]
4. Distribution of Na+/I- symporter in thyroid cancers in an iodine-deficient population: an immunohistochemical study.
Mishra A; Pal L; Mishra SK
World J Surg; 2007 Sep; 31(9):1737-1742. PubMed ID: 17653791
[TBL] [Abstract][Full Text] [Related]
5. [Expression and significance of serum E-cadherin in patients with papillary thyroid carcinoma].
Sun L; Wang DM; Zhang WJ; Zhang J; Wu JF
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(2):123-126. PubMed ID: 29871201
[No Abstract] [Full Text] [Related]
6. Analysis of the sodium iodide symporter expression in histological slides from a nodular goiter.
Syrenicz A; Wolny M; Kram A; Sworczak K; Syrenicz M; Garanty-Bogacka B; Walczak M
Arch Med Res; 2007 Feb; 38(2):219-26. PubMed ID: 17227732
[TBL] [Abstract][Full Text] [Related]
7. Expression of NIS, VEGF-A and Thyroid Autoantibody in Papillary Thyroid Carcinoma with or without Hashimoto's Disease.
Ma Y; He J; Shen N; Guo R
ORL J Otorhinolaryngol Relat Spec; 2019; 81(5-6):281-286. PubMed ID: 31480047
[TBL] [Abstract][Full Text] [Related]
8. Expression of the sodium iodide symporter and thyroglobulin genes are reduced in papillary thyroid cancer.
Ringel MD; Anderson J; Souza SL; Burch HB; Tambascia M; Shriver CD; Tuttle RM
Mod Pathol; 2001 Apr; 14(4):289-96. PubMed ID: 11301345
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of sodium iodide symporter expression in metastatic differentiated thyroid cancer: correlation with radioiodine uptake.
Castro MR; Bergert ER; Goellner JR; Hay ID; Morris JC
J Clin Endocrinol Metab; 2001 Nov; 86(11):5627-32. PubMed ID: 11701745
[TBL] [Abstract][Full Text] [Related]
10. Different Expression of Erythrocyte Sedimentation Rate and C-reactive Protein in Papillary Thyroid Carcinoma and Nodular Goiter.
Hou X; Jiang L; Chen C; Zhu X; Ge M
Clin Lab; 2015; 61(7):793-9. PubMed ID: 26299079
[TBL] [Abstract][Full Text] [Related]
11. Use of sodium iodide symporter expression in differentiated thyroid carcinomas.
Morari EC; Marcello MA; Guilhen AC; Cunha LL; Latuff P; Soares FA; Vassallo J; Ward LS
Clin Endocrinol (Oxf); 2011 Aug; 75(2):247-54. PubMed ID: 21521301
[TBL] [Abstract][Full Text] [Related]
12. Relationship of sodium/iodide symporter expression with I131 whole body scan uptake between primary and metastatic lymph node papillary thyroid carcinomas.
Lee SJ; Choi KC; Han JP; Park YE; Choi MG
J Endocrinol Invest; 2007 Jan; 30(1):28-34. PubMed ID: 17318019
[TBL] [Abstract][Full Text] [Related]
13. Differentiated thyroid carcinoma that express sodium-iodide symporter have a lower risk of recurrence for children and adolescents.
Patel A; Jhiang S; Dogra S; Terrell R; Powers PA; Fenton C; Dinauer CA; Tuttle RM; Francis GL
Pediatr Res; 2002 Nov; 52(5):737-44. PubMed ID: 12409522
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical studies of Na+/I- symporter in human thyroid tissues--a correlation with clinical thyroid scintigraphy.
Lee CH; Yang AH; Chang JY; Huang CL; Chi CW
Zhonghua Yi Xue Za Zhi (Taipei); 2001 Mar; 64(3):141-6. PubMed ID: 11458618
[TBL] [Abstract][Full Text] [Related]
15. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
Jiang XL; Zhang H; Chen YL; Peng L
Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
[No Abstract] [Full Text] [Related]
16. Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism.
Filetti S; Bidart JM; Arturi F; Caillou B; Russo D; Schlumberger M
Eur J Endocrinol; 1999 Nov; 141(5):443-57. PubMed ID: 10576759
[TBL] [Abstract][Full Text] [Related]
17. Effects of BRAF(V600E) mutation on Na(+)/I(-) symporter expression in papillary thyroid carcinoma.
Dong H; Shen WZ; Yan YJ; Yi JL; Zhang L
J Huazhong Univ Sci Technolog Med Sci; 2016 Feb; 36(1):77-81. PubMed ID: 26838744
[TBL] [Abstract][Full Text] [Related]
18. Expression of prostaglandin E2 and EP receptors in human papillary thyroid carcinoma.
Sun L; Wei X; Liu X; Zhou D; Hu F; Zeng Y; Sun Y; Luo S; Zhang Y; Yi XP
Tumour Biol; 2016 Apr; 37(4):4689-97. PubMed ID: 26511970
[TBL] [Abstract][Full Text] [Related]
19. Sodium/iodide symporter (NIS) and pendrin are expressed differently in hot and cold nodules of thyroid toxic multinodular goiter.
Russo D; Bulotta S; Bruno R; Arturi F; Giannasio P; Derwahl M; Bidart JM; Schlumberger M; Filetti S
Eur J Endocrinol; 2001 Nov; 145(5):591-7. PubMed ID: 11720877
[TBL] [Abstract][Full Text] [Related]
20. Differential expression patterns of estrogen receptor (ER)-β splice variants between papillary thyroid cancer and nodular thyroid goiter.
Dong W; Li J; Huang Y; Zhang H; Shan Z; Teng W
Med Sci Monit; 2012 Sep; 18(9):BR351-5. PubMed ID: 22936184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
